ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

SLDB Company Profile and Key Details

NASDAQ : SLDB

Solid Biosciences Inc.

$3.69

0.245+7.11%

At Close 4:00 PM

63.06

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

SLDB Stock Price Chart

Stock Price Today

Solid Biosciences Inc. (SLDB) stock surged +7.11%, trading at $3.69 on NASDAQ, up from the previous close of $3.45. The stock opened at $3.32, fluctuating between $3.21 and $3.76 in the recent session.

Stock Snapshot

3.445

Prev. Close

3.32

Open

285.95M

Market Cap

77.49M

Number of Shares

3.21

Day Low

3.755

Day High

-1.21

P/E Ratio

86.58%

Free Float in %

-3.06

EPS (TTM)

6.2

Book Value

-4.69

Cash Flow per Share

1.76M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	3.32	3.76	3.21	3.69	1.79M
Apr 01, 2025	3.76	3.77	3.43	3.45	1.86M
Mar 31, 2025	3.91	4.05	3.50	3.70	2.11M
Mar 28, 2025	4.37	4.44	4.22	4.32	496.22K
Mar 27, 2025	4.23	4.41	4.12	4.37	881.49K
Mar 26, 2025	4.46	4.48	4.18	4.26	807.12K
Mar 25, 2025	4.79	4.86	4.45	4.49	741.43K
Mar 24, 2025	4.62	4.80	4.62	4.78	1.16M
Mar 21, 2025	4.65	4.72	4.50	4.60	1.04M
Mar 20, 2025	4.82	4.95	4.62	4.70	954.43K
Mar 19, 2025	4.90	4.95	4.58	4.82	1.25M
Mar 18, 2025	5.31	5.46	4.89	4.93	1.83M
Mar 17, 2025	5.02	5.39	4.90	5.36	851.68K
Mar 14, 2025	5.21	5.31	4.99	5.09	932.82K
Mar 13, 2025	5.56	5.73	5.14	5.15	1.02M
Mar 12, 2025	5.60	5.85	5.54	5.73	1.27M
Mar 11, 2025	4.98	5.64	4.87	5.61	1.45M
Mar 10, 2025	5.52	5.60	4.96	5.09	1.74M
Mar 07, 2025	5.25	5.79	5.25	5.42	1.67M
Mar 06, 2025	5.64	5.77	5.48	5.50	717.5K

Contact Details

Cambridge, MA 02139

United States

Website: https://www.solidbio.comContact: 617 337 4680

About Company

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Solid Biosciences Inc. (SLDB) stock price?

Solid Biosciences Inc. (NASDAQ: SLDB) stock price is $3.69 in the last trading session. During the trading session, SLDB stock reached the peak price of $3.76 while $3.21 was the lowest point it dropped to. The percentage change in SLDB stock occurred in the recent session was 7.11% while the dollar amount for the price change in SLDB stock was $0.25.

SLDB's industry and sector of operation?

The NASDAQ listed SLDB is part of Biotechnology industry that operates in the broader Healthcare sector. Solid Biosciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SLDB?

Mr. Ilan Ganot
Co-founder, Strategic Advisor to the Chief Executive Officer & Director
Mr. Gilad David Hayeem
Co-Founder
Mr. Stephen J. Di Palma M.B.A, M.B.A.
Consultant
Mr. David Tyronne Howton Jr., J.D.
Chief Admin. Officer & Sec.
Ms. Erin Powers Brennan
Chief Legal Officer & Sec.
Mr. Paul Herzich
Chief Technology Officer
Dr. Carl Ashley Morris Ph.D.
Chief Scientific Officer of Neuromuscular
Mr. Ian F. Smith A.C.A., ACA, C.P.A., CPA
Executive Chair
Mr. Alexander G. Cumbo
Pres, Chief Executive Officer & Director
Mr. Matthew Bennett Arnold
Co-Founder & Board Member
Ms. Annie Ganot
Co-Founder & Head of Patient Advocacy
Dr. Andrey Juan Zarur Ph.D.
Co-Founder
Mr. Kevin Tan C.F.A.
Chief Financial Officer & Treasurer

How SLDB did perform over past 52-week?

SLDB's closing price is 28.12% higher than its 52-week low of $2.88 where as its distance from 52-week high of $12.95 is -71.51%.

How many employees does SLDB have?

Number of SLDB employees currently stands at 100.

Link for SLDB official website?

Official Website of SLDB is: https://www.solidbio.com

How do I contact SLDB?

SLDB could be contacted at phone 617 337 4680 and can also be accessed through its website. SLDB operates from 141 Portland Street, Cambridge, MA 02139, United States.

How many shares of SLDB are traded daily?

SLDB stock volume for the day was 1.76M shares. The average number of SLDB shares traded daily for last 3 months was 2.49M.

What is the market cap of SLDB currently?

The market value of SLDB currently stands at $285.95M with its latest stock price at $3.69 and 77.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	100
Beta	1.98
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology